Olga Veremchuk, M.D.

Olga Veremchuk joined Immatics in November 2022 and is responsible for Clinical Development. Olga acts as a program physician lead and medical monitor and is taking on additional tasks within the TCR Bispecifics (TCER®) programs.

Olga is a board-certified physician in internal medicine and oncology and brings over 15 years of experience in medical oncology and clinical research in phase I-IV trials mostly in solid tumors, but also hematology malignancies and rare diseases. In the last years Olga was mainly involved in the field of immune-oncology trials.Olga moved to Immatics from a large CRO (ICON) where she was a Director of Medical Affairs, Oncology and Hematology leading a team of Medical Directors.

Olga provided oversight to global initiatives and partnerships, was involved in trial design and  development of clinical protocols. She acted as a Medical Monitor in selected trials and contributed to several drug approvals in the US and Europe. Olga worked for 5 years as a practicing physician at the Kyiv City Clinical Hospital, Ukraine.

Olga gained her M.D. from National Medical University by O.O. Bogomolets, Kyiv, Ukraine.